Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 11, Pages 3684
Publisher
MDPI AG
Online
2018-11-22
DOI
10.3390/ijms19113684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells
- (2017) Paul A. Clark et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
- (2017) Narasimha Kumar Karanam et al. Cell Death & Disease
- Biological activity of tumor-treating fields in preclinical glioma models
- (2017) Manuela Silginer et al. Cell Death & Disease
- A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications
- (2015) Sujuan Guo et al. Autophagy
- Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
- (2015) Nidhi Gera et al. PLoS One
- Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
- (2015) Moshe Giladi et al. Scientific Reports
- Inhibition of brain tumor cell proliferation by alternating electric fields
- (2014) Hyesun Jeong et al. APPLIED PHYSICS LETTERS
- Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles
- (2014) Giuseppe M. V. Barbagallo et al. Neurosurgical Focus
- Post Hoc Analyses of Intention-to-Treat Population in Phase III Comparison of NovoTTF-100A™ System Versus Best Physician’s Choice Chemotherapy
- (2014) Andrew A. Kanner et al. SEMINARS IN ONCOLOGY
- Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial
- (2013) E. Galanis et al. CLINICAL CANCER RESEARCH
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas
- (2012) Robert B. Den et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
- (2012) E. Q. Lee et al. NEURO-ONCOLOGY
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme
- (2010) John D. Hainsworth et al. CANCER
- Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
- (2010) Margaret A. Park et al. CANCER BIOLOGY & THERAPY
- Sorafenib: Where do we go from here?
- (2010) Abby B. Siegel et al. HEPATOLOGY
- Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro
- (2010) Ullén INTERNATIONAL JOURNAL OF ONCOLOGY
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Performance evaluation of an Inveon PET preclinical scanner
- (2009) Cristian C Constantinescu et al. PHYSICS IN MEDICINE AND BIOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now